Nobutaka Ohta
About
In The Last Decade
Nobutaka Ohta
27 papers receiving 479 citations
Peers
Comparison fields: 5 of 92
- Oncology 155
- Pulmonary and Respiratory Medicine 141
- Urology 82
- Pediatrics, Perinatology and Child Health 72
- Electrical and Electronic Engineering 70
Countries citing papers authored by Nobutaka Ohta
This map shows the geographic impact of Nobutaka Ohta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobutaka Ohta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobutaka Ohta more than expected).
Fields of papers citing papers by Nobutaka Ohta
This network shows the impact of papers produced by Nobutaka Ohta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobutaka Ohta. The network helps show where Nobutaka Ohta may publish in the future.
Co-authorship network of co-authors of Nobutaka Ohta
This figure shows the co-authorship network connecting the top 25 collaborators of Nobutaka Ohta. A scholar is included among the top collaborators of Nobutaka Ohta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobutaka Ohta. Nobutaka Ohta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 85 | |
| 4 | 15 | |
| 5 | 9 | |
| 6 | 91 | |
| 7 | 4 | |
| 8 | 6 | |
| 9 | 19 | |
| 10 | 9 | |
| 11 | 12 | |
| 12 | 2 | |
| 13 | 33 | |
| 14 | 1 | |
| 15 | 8 | |
| 16 | 22 | |
| 17 | 1 | |
| 18 | 27 | |
| 19 | 5 | |
| 20 | EFFECT OF PEPLEOMYCIN (BLEOMYCIN DERIVATIVE, NK 631) ON PROSTATIC CANCER | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.